Lipid Nanoparticles

Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing

Jim Ziogas

DIANT Pharma

mRNA Innovations

Technology Advances Needed to Drive Future mRNA Growth

Hagen Richter, Ph.D.

mRNA Manufacturing

Navigating mRNA Manufacturing with Flexibility and Innovation

Michael van der Horst, Ph.D.

Nice Insight Reports

Biotech Funding Ups and Downs

April Stanley, MS MBA

pDNA Manufacturing

Overcoming pDNA Supply Challenges for mRNA Manufacturing

Mack Kuo, Ph.D.

mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

Lipid Nanoparticles

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Antonio Costa, Ph.D.

DIANT Pharma

Morpholinos

Modifying RNA Splicing with Morpholinos

Jon Moulton, Ph.D.

Gene Tools

Digitalization, AI, and Automation

Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds

CRB

New Integrated mRNA Offering

Building on Experience and Investing in an Integrated mRNA Offering

Jessica Madigan; Normand Blais

BIOVECTRA

Risk Management in mRNA Manufacture

Managing Risk in Cutting-Edge mRNA Therapeutics

Jessica Madigan; Normand Blais

BIOVECTRA

Continuous Processing

US Food and Drug Administration (FDA) Purchase the LiFT System from DIANT® Pharma INC.

DIANT Pharma

Oncology

Addressing Cancer Therapy Resistance by Targeting Translational Regulation

Steve Worland, Ph.D.

eFFECTOR

Lipid Nanoparticles

Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

RNA Manufacturing

Exothera Nucleic Acids will be the World’s First CDMO with Access to Quantoom’s Revolutionary Nfinity™ Platform for the continuous production of RNA which Exothera will offer as a service.

Exothera

Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development

Martin Akerman, Ph.D.

Envisagenics

mRNA Ultra-Cold Chain Management

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

Eunseo (Ency) Lee, Ph.D; Jungkeun (Henry) Oh; Hanel Hwang

Samsung Biologics

Lipid Nanoparticles

Lipid Nanoparticles: Transforming the Nanomedicines Market

Antonio Costa, Ph.D.

DIANT Pharma

Gene Tools

Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos

David Alvaro, Ph.D.; Jon Moulton, Ph.D.

Pharma's Almanac

Lipid Nanoparticle Development

Lipid Technology for Delivery of Gene-Editing Therapies

Stephen Burgess, Ph.D.

Croda Pharma